Allianz Asset Management
NVO

Allianz Asset Management’s Novo Nordisk NVO Stock Holding History

Allianz Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,200
Closed -$664K – 2244
2023
Q2 		$664K Hold
8,200
– – ﹤0.01% 1661
2023
Q1 		$652K Buy
+8,200
New +$581K ﹤0.01% 1826
2022
Q3 		– Sell
-179,552
Closed -$10M – 2045
2022
Q2 		$10M Buy
179,552
+47,062
+36% +$2.61M 0.01% 898
2022
Q1 		$7.36M Sell
132,490
-1,556
-1% -$79.9K 0.01% 1084
2021
Q4 		$7.51M Sell
134,046
-18,638
-12% -$1.01M 0.01% 1089
2021
Q3 		$7.33M Buy
152,684
+113,794
+293% +$5.5M 0.01% 1130
2021
Q2 		$1.63M Sell
38,890
-3,504
-8% -$136K ﹤0.01% 1544
2021
Q1 		$1.43M Buy
42,394
+2,348
+6% +$83.6K ﹤0.01% 1516
2020
Q4 		$1.4M Buy
40,046
+8,330
+26% +$288K ﹤0.01% 1402
2020
Q3 		$1.1M Buy
31,716
+742
+2% +$24.7K ﹤0.01% 1404
2020
Q2 		$1.01M Buy
30,974
+11,666
+60% +$372K ﹤0.01% 1823
2020
Q1 		$581K Buy
19,308
+3,442
+22% +$102K ﹤0.01% 1997
2019
Q4 		$459K Buy
15,866
+2,852
+22% +$79K ﹤0.01% 2458
2019
Q3 		$336K Buy
13,014
+1,000
+8% +$25.3K ﹤0.01% 2490
2019
Q2 		$306K Buy
12,014
+884
+8% +$21.8K ﹤0.01% 2494
2019
Q1 		$291K Buy
11,130
+1,470
+15% +$36.1K ﹤0.01% 2489
2018
Q4 		$223K Buy
+9,660
New +$215K ﹤0.01% 2487
2018
Q1 		– Sell
-7,734
Closed -$208K – 2700
2017
Q4 		$208K Buy
+7,734
New +$197K ﹤0.01% 2594

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allianz Asset Management's NVO Position: Q3 2023 in Review

Allianz Asset Management sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 8,200 shares — an estimated $664K sold.

Allianz Asset Management first reported a position in NVO in Q4 2017 and held it in 18 quarters. The position peaked at $10M in Q2 2022. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • Allianz Asset Management reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
  • Allianz Asset Management sold 8,200 Novo Nordisk shares in Q3 2023, an estimated $664K.
  • Allianz Asset Management first reported a position in Novo Nordisk in Q4 2017 and held it in 18 quarters.
  • Allianz Asset Management's Novo Nordisk position peaked at $10M in Q2 2022.
  • 1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Allianz Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.